Granisetron transdermal system
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Granisetron transdermal system, covering 2017-11-17 to 2017-11-17. Get the full timeline:
Most recent: Clinical Trial Update: Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy [Phase 1]